Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

BioExx Specialty Proteins Ltd BIXZF

"Bioexx Specialty Proteins Inc is engaged in the development and commercialization of processing technologies, for use in the extracting various active ingredients from organic and inorganic materials. The company's primary focus is on the production of proteins from canola and other oilseed feedstocks. Its products include Isolexx, a protein isolate for use in bakery products, meat products, vegetarian food products and meat analogues, and nutritional and protein bars, drinks, and supplements;


GREY:BIXZF - Post by User

Comment by buckrodon Aug 04, 2013 3:11am
423 Views
Post# 21648993

RE:accounting question

RE:accounting question"The ITA (5) (a) (i) requires that, in order for the previous non capital losses to be deductible subsequent to a change in control, the acquired business must be carried on with a reasonable expectation of profit. In the absence of an expectation of profit these losses would no longer be deductible and would become worthless. Therefore, purchasing a business only for the use of its existing tax losses would not be allowed, as it would be argued that no reasonable expectation of profit could be expected. (and even if this argument were not successful, the GAAR would come into play).    

So make of this what you will but Bioexx as a business will not be carried on with a reasonable expectation of profit by the aquirer. The building land etc is all sold and dispersed of as a business to make proteins. So I feel the carry over tax loss would be worthless to any aquirer. The best that could be hoped for is that they sell the patents and IP for lets say 10 million if they are lucky, and if no more burn through this 2-3 cents a share could be dispersed to common shareholders. But I doubt that. Chris S is the only one with large money in his pocket from this mess and doesn't care at all about the common shareholder. The debenture holders will get their money back, Chris s et all, and that will likely be all after IP sale. 
 
<< Previous
Bullboard Posts
Next >>